Vision and Mission
Our Team
Corporate History
Global Reach
Clinilabs Green
Upcoming Events
Media Events
Press Releases
Publications
Webinars
Clinilabs: Early Phase and Specialty Clinical Drug Development
About Us Our Services Investigators Volunteers Careers Contact
 
 

Press Release

CLINILABS MAKES INC. 5000 LIST OF FASTEST GROWING COMPANIES

New York, NY (September 25, 2008) – Clinilabs, Inc., a specialty contract research organization (CRO), is pleased to announce that it has been ranked No. 2699 on the 2008 Inc. 5000 list of fastest growing companies, with a three-year sales growth of 135.3%. This was the first time the Company submitted an application for the prestigious list.

Inc. 5000 list takes a comprehensive look at America’s independent-minded entrepreneurs. The list measured companies’ revenue growth from 2004 through 2007 and the 5000 companies that made the list reported combined revenue of $185 billion and median three-year growth of 147%. In order to qualify for the list, companies must be US based, privately held and independent, and have had at least $200,000 in revenue in 2004, and $2 million in 2007.

“Clinilabs is honored to be ranked in Inc. 5000 list. It is a satisfying accomplishment for both the Company and its employees to be ranked among this group of successful companies,” stated Dr. Gary Zammit, Clinilabs’ President & CEO.

“Our second annual Inc. 5000 continues the most ambitious project in business journalism,” said Inc. 5000 Project Manager, Jim Melloan. “The Inc. 5000 gives an unrivalled portrait of young, underreported companies across all industries doing fascinating things with cutting-edge business models, as well as older companies that are still showing impressive growth.”

Clinilabs is committed to the clinical development of new drug products by providing comprehensive early-phase clinical development services at its state-of-the-art clinical research unit, and clinical trial data management services, including electronic data capture and integration at its core data center. The Company has deep therapeutic expertise in CNS and cardiovascular drugs, including those under development for sleep, cognitive, affective, and neurological disorders.

The Company founded a charity organization called Nite Lights, which aims to improve the health and well-being of sick children by helping them get the sleep they need. Through this organization, Clinilabs provides sleep essentials such as beds, bedding, pajamas, slippers, a robe, and nighttime aids to impoverished children with acute or chronic medical illnesses. For more information on Nite Lights, please visit www.nightlites.org.

About Clinilabs, Inc.

Clinilabs is a specialty contract research organization (CRO) that provides a comprehensive portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in early phase drug development, with deep expertise in central nervous system (CNS) and cardiovascular (CV) therapeutics. The Company also provides data management for multicenter trials through a core data center that delivers services efficiently, promptly, and cost effectively. Established in 2001, Clinilabs has been the vendor of choice for more than one third of the world’s top 20 pharmaceutical companies, and has been involved in 7 successful New Drug Applications (NDAs). For more information, please visit www.clinilabs.com.

About Inc.com

Inc.com, the daily resource for entrepreneurs, delivers how-to guides, advice, tools, breaking news, and rich multi-media to help business owners and CEOs start, run, and grow their businesses. Inc.com offers dynamic marketing solutions to help advertisers effectively reach Inc.com's audience of business leaders. Visit www.inc.com.


Contact:
Jeanine M. Estrada
212-981-2716
jestrada@clinilabs.com



 

 

 

 

 

 

 

 

 

 

 

 

 



 

   
Join the Conversation
Facebook
Twitter
Linked In
YouTube
RSS Feed